Your browser doesn't support javascript.
loading
A Phase I Trial of VEGF-A Inhibition Combined with PD-L1 Blockade for Recurrent Glioblastoma.
Chiu, Daniel; Qi, Jingjing; Thin, Tin Htwe; Garcia-Barros, Monica; Lee, Brian; Hahn, Mary; Mandeli, John; Belani, Puneet; Nael, Kambiz; Rashidipour, Omid; Ghatan, Saadi; Hadjipanayis, Constantinos G; Yong, Raymund L; Germano, Isabelle M; Brody, Rachel; Tsankova, Nadejda M; Gnjatic, Sacha; Kim-Schulze, Seunghee; Hormigo, Adília.
Afiliación
  • Chiu D; Icahn School of Medicine at Mount Sinai, New York, New York.
  • Qi J; Departments of Oncological Sciences, Medicine (Hematology/Oncology), and Pathology and Precision Immunology Institute, Human Immune Monitoring Center, Tisch Cancer Institute, Icahn School of Medicine at Mount Sinai, New York, New York.
  • Thin TH; Department of Pathology, Mount Sinai Medical Center, New York, New York.
  • Garcia-Barros M; Department of Pathology, Mount Sinai Medical Center, New York, New York.
  • Lee B; Departments of Oncological Sciences, Medicine (Hematology/Oncology), and Pathology and Precision Immunology Institute, Human Immune Monitoring Center, Tisch Cancer Institute, Icahn School of Medicine at Mount Sinai, New York, New York.
  • Hahn M; Icahn School of Medicine at Mount Sinai, New York, New York.
  • Mandeli J; Environmental Medicine and Public Health, Mount Sinai Medical Center, New York, New York.
  • Belani P; Diagnostic, Molecular & Interventional Radiology, Mount Sinai Medical Center, New York, New York.
  • Nael K; Department of Radiological Sciences, David Geffen School of Medicine, University of California Los Angeles, Los Angeles, California.
  • Rashidipour O; Department of Pathology, Mount Sinai Medical Center, New York, New York.
  • Ghatan S; Departments of Oncological Sciences, Medicine (Hematology/Oncology), and Pathology and Precision Immunology Institute, Human Immune Monitoring Center, Tisch Cancer Institute, Icahn School of Medicine at Mount Sinai, New York, New York.
  • Hadjipanayis CG; Departments of Neurological Surgery and Oncological Sciences, Icahn School of Medicine at Mount Sinai, New York, New York.
  • Yong RL; Departments of Neurological Surgery and Oncological Sciences, Icahn School of Medicine at Mount Sinai, New York, New York.
  • Germano IM; Departments of Neurological Surgery and Oncological Sciences, Icahn School of Medicine at Mount Sinai, New York, New York.
  • Brody R; Departments of Neurological Surgery and Oncological Sciences, Icahn School of Medicine at Mount Sinai, New York, New York.
  • Tsankova NM; Department of Pathology, Mount Sinai Medical Center, New York, New York.
  • Gnjatic S; Department of Pathology, Mount Sinai Medical Center, New York, New York.
  • Kim-Schulze S; Departments of Oncological Sciences, Medicine (Hematology/Oncology), and Pathology and Precision Immunology Institute, Human Immune Monitoring Center, Tisch Cancer Institute, Icahn School of Medicine at Mount Sinai, New York, New York.
  • Hormigo A; Departments of Oncological Sciences, Medicine (Hematology/Oncology), and Pathology and Precision Immunology Institute, Human Immune Monitoring Center, Tisch Cancer Institute, Icahn School of Medicine at Mount Sinai, New York, New York.
Cancer Res Commun ; 3(1): 130-139, 2023 01.
Article en En | MEDLINE | ID: mdl-36968223
Asunto(s)
Texto completo
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Colección: 01-internacional Banco de datos: MEDLINE Asunto principal: Glioblastoma Límite: Humans / Middle aged Idioma: En Revista: Cancer Res Commun Año: 2023 Tipo del documento: Article
Texto completo
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Colección: 01-internacional Banco de datos: MEDLINE Asunto principal: Glioblastoma Límite: Humans / Middle aged Idioma: En Revista: Cancer Res Commun Año: 2023 Tipo del documento: Article